• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Primary Biliary Cholangitis
Tags
  • Primary Biliary Cholangitis

 

Study title Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
Disease or condition Primary Biliary Cholangitis
Study type Interventional (clinical trial)
Intervention/treatment Seladelpar (capsule)
Phase 3
Study site Duke University
Study location Durham, NC
Principal investigator name Andrew Muir, MD
Study coordinator name and email Christy Walters, RN christy.walters@duke.edu
Phone contact 919-668-5499
Clinicaltrials.gov link https://www.clinicaltrials.gov/ct2/show/NCT03301506

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE